HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
16 hedge funds and large institutions have $420K invested in Hepion Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$360K |
2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$43.4K |
3 |
HF
HRT Financial
New York
|
+$7K |
4 |
Citadel Advisors
Miami,
Florida
|
+$6.7K |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$43 |
Top Sellers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23.6K |
2 |
Geode Capital Management
Boston,
Massachusetts
|
-$21.2K |
3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$12.2K |
4 |
Renaissance Technologies
New York
|
-$8.16K |
5 |
State Street
Boston,
Massachusetts
|
-$7.37K |